Argatroban, a new treatment option for heparin-induced thrombocytopenia

MeSH terms

• Anticoagulants / adverse effects*
• Antithrombins / economics
• Antithrombins / pharmacology
• Antithrombins / therapeutic use*
• Arginine / analogs & derivatives
• Blood Coagulation / drug effects
• Blood Coagulation Tests
• Chondroitin Sulfates / economics
• Chondroitin Sulfates / pharmacology
• Chondroitin Sulfates / therapeutic use
• Critical Care / methods
• Dermatan Sulfate / economics
• Dermatan Sulfate / pharmacology
• Dermatan Sulfate / therapeutic use
• Drug Combinations
• Drug Costs
• Drug Monitoring / methods
• Heparin / adverse effects*
• Heparitin Sulfate / economics
• Heparitin Sulfate / pharmacology
• Heparitin Sulfate / therapeutic use
• Hirudins / analogs & derivatives*
• Hirudins / economics
• Hirudins / pharmacology
• Humans
• Pipecolic Acids / economics
• Pipecolic Acids / pharmacology
• Pipecolic Acids / therapeutic use*
• Recombinant Proteins / economics
• Recombinant Proteins / pharmacology
• Recombinant Proteins / therapeutic use
• Sulfonamides
• Thrombocytopenia / chemically induced*
• Thrombocytopenia / classification
• Thrombocytopenia / drug therapy*